{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/urticaria/","result":{"data":{"firstChapter":{"id":"7068e840-7bdb-5596-a56f-1c930bd4b8c4","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 2391b588-e1e0-43e7-9e0d-1bb429d57571 --><h1>Urticaria: Summary</h1><!-- end field 2391b588-e1e0-43e7-9e0d-1bb429d57571 -->","htmlStringContent":"<!-- begin item 256d8551-003e-4cc9-83f8-9b3b76782e28 --><!-- begin field 838e9e27-7f27-4e43-8a67-e882579ef366 --><ul><li>Urticaria is a superficial swelling of the skin (epidermis and mucous membranes) that results in a red, raised, itchy rash.<ul><li>Angio-oedema is a deeper form of urticaria with swelling in the dermis and submucosal or subcutaneous tissues.</li></ul></li><li>Urticaria can be classified according to its duration as:<ul><li>Acute — symptoms last for less than 6 weeks.  </li><li>Chronic — symptoms persist for 6 weeks or longer, on a nearly daily basis.  </li></ul></li><li>Chronic urticaria is further classified as:<ul><li>Chronic spontaneous urticaria (previously called chronic idiopathic urticaria) — this has no identifiable external cause but may be aggravated by heat, stress, certain drugs, and infections. </li><li>Autoimmune urticaria — characterized by the presence of immunoglobulin G (IgG) autoantibodies to the high-affinity receptor for IgE (Fc epsilon R1). </li><li>Chronic inducible urticaria (CINDU, previously called physical urticaria) — occurs in response to a physical stimulus and can be further classified according to its cause as aquagenic, cholinergic, solar, cold, heat, dermatographism, delayed pressure, vibratory, and contact urticaria.</li></ul></li><li>Investigations are not usually required for the diagnosis of urticaria, but may be indicated (after a thorough history and physical examination) to identify associated conditions or trigger factors, or to exclude differential diagnoses. </li><li>To manage urticaria, the underlying cause should be identified and managed, where possible.</li><li>Acute urticaria is likely to be self-limiting without treatment.</li><li>People with symptoms requiring treatment should be offered a non-sedating antihistamine to be taken daily for up to 6 weeks. For severe symptoms, a short course (up to 7 days) of an oral corticosteroid should also be offered.</li><li>If symptoms improve, consideration should be given to prescribing antihistamine treatment daily for<strong> </strong>3–6 months (if it is thought likely that symptoms will be persistent or recurrent), or as required or prophylactically (for people with infrequent symptoms). </li><li>If response to treatment is inadequate, the following options should be considered (using clinical judgement):<ul><li>Gradually increasing the dose of the first-line antihistamine to up to four times the licensed dose (off-label use).</li><li>An alternative non-sedating antihistamine.</li><li>Adding a topical antipruritic agent (such as calamine lotion) to relieve itch.</li><li>Adding a sedating antihistamine (such as chlorphenamine) at night, if itch is interfering with sleep.</li><li>Referral to a dermatologist or immunologist.</li></ul></li><li>Referral to a dermatologist or immunologist should also be arranged if:<ul><li>Vasculitic urticaria (inflammation of blood vessels due to an autoimmune reaction) is suspected (for example if urticaria is painful and persistent).</li><li>The person has a food or latex allergy, or a form of CINDU that may be difficult to manage in primary care (for example solar or cold urticaria).</li></ul></li><li>Referral to a clinical psychologist should be arranged for people whose symptoms are adversely affecting their quality of life, for example causing significant social or psychological problems.</li></ul><!-- end field 838e9e27-7f27-4e43-8a67-e882579ef366 --><!-- end item 256d8551-003e-4cc9-83f8-9b3b76782e28 -->","topic":{"id":"bfdbbcbf-5a56-51b8-b0aa-78a059b4cfec","topicId":"73ccd3ba-b5a5-4a3c-98b2-d838dd8a3c58","topicName":"Urticaria","slug":"urticaria","aliases":[],"chapters":[{"id":"7068e840-7bdb-5596-a56f-1c930bd4b8c4","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"d6e4cfbd-5e36-5755-a780-8091e4b5f146","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9dde1c08-758f-55bb-b187-0203ded94048","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3daa7b54-d234-587b-8a56-1bb5cae1efe4","slug":"changes","fullItemName":"Changes"},{"id":"54c42276-0c06-5c18-825f-3c440cb30dfe","slug":"update","fullItemName":"Update"}]},{"id":"5cff12c3-445b-5613-bf5d-dc48effe6502","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"9abed54c-a9ed-58d4-bfce-3f0dddd49698","slug":"goals","fullItemName":"Goals"},{"id":"c2f713b4-e2ec-5e5e-be8f-5c4285be0b6e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e829abf6-8412-500f-9425-647958addf97","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"92b040fe-6318-560a-9ae0-6f98a6aa9c09","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2d2f38df-88c4-5895-915d-199eefc9b02a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d51180cd-461f-58ad-8f03-20d63965abfb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a7fce165-b445-5aa6-9ec9-6ec8016f4bee","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"a5d17f35-ddfe-5931-bfe4-b7dc039baea0","slug":"definition","fullItemName":"Definition"},{"id":"90888c1e-cd37-5fdf-9d0d-b71e51bf56c3","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"76d2cc5e-4a3e-5032-8eed-d4010ace1ae7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"507a6931-af71-54ae-a8e7-2b4393c2a41b","slug":"complications","fullItemName":"Complications"},{"id":"091f4740-5801-5ac0-83bd-a7ebbc2a2848","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"fc3a9cf3-3dd4-5456-94e1-90c38c83a0b1","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"513fb45b-36c0-59b5-8f88-13b10509caee","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e2100cac-0eb7-55e6-b138-9cbc110f1b71","slug":"investigations","fullItemName":"Investigations"},{"id":"2da7bf77-7798-5632-97d4-64d5463f8cde","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1a1cabda-9d82-5131-8852-db2d844e0b46","slug":"management","fullItemName":"Management","subChapters":[{"id":"f797a7bd-9ca9-523b-8f1e-e2afc927c4ab","slug":"managing-urticaria","fullItemName":"Scenario: Managing urticaria"}]},{"id":"3c7854e6-2fe5-5632-9b63-69f2773b7dd1","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"71f6ce5f-ac94-5ef4-9a02-0aa362883a44","slug":"non-sedating-antihistamines","fullItemName":"Non-sedating antihistamines"},{"id":"8888f0f6-7dd8-55fb-afc0-9e5df55b825a","slug":"sedating-antihistamines","fullItemName":"Sedating antihistamines"},{"id":"b8336773-e3de-5ec0-a85b-93fd72ff7869","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"c88fe5a9-a559-5661-9a1f-e0ee93078a4d","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"e9950b4f-8af1-5d4b-b531-431ac4a731bb","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"729aa2a2-070b-51ed-9ecf-c29549914b66","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a30a2a17-7629-5022-a313-848d8264fb35","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f6d1c75a-6a3d-5326-97ca-baff36370740","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"dd5a897e-e7d5-5c98-88b6-35014f9a5dde","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6d27a969-ded2-5d9d-9321-f65e47426edf","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0d45859d-1b50-538f-84fa-568f43b5c283","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"bfdbbcbf-5a56-51b8-b0aa-78a059b4cfec","topicId":"73ccd3ba-b5a5-4a3c-98b2-d838dd8a3c58","topicName":"Urticaria","slug":"urticaria","aliases":[],"topicSummary":"Urticaria is a superficial swelling of the skin (epidermis and mucous membranes) that results in a red, raised, itchy rash.","lastRevised":"Last revised in March 2020","nextPlannedReviewBy":"2022-03-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2022-03","nextPlannedReviewByDisplay":"March 2022","specialities":[{"id":"861c4fe3-02c7-51e0-8f03-a114c375ba4d","name":"Allergies","slug":"allergies"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"7068e840-7bdb-5596-a56f-1c930bd4b8c4","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"d6e4cfbd-5e36-5755-a780-8091e4b5f146","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"9dde1c08-758f-55bb-b187-0203ded94048","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3daa7b54-d234-587b-8a56-1bb5cae1efe4","slug":"changes","fullItemName":"Changes"},{"id":"54c42276-0c06-5c18-825f-3c440cb30dfe","slug":"update","fullItemName":"Update"}]},{"id":"5cff12c3-445b-5613-bf5d-dc48effe6502","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"9abed54c-a9ed-58d4-bfce-3f0dddd49698","slug":"goals","fullItemName":"Goals"},{"id":"c2f713b4-e2ec-5e5e-be8f-5c4285be0b6e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e829abf6-8412-500f-9425-647958addf97","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"92b040fe-6318-560a-9ae0-6f98a6aa9c09","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2d2f38df-88c4-5895-915d-199eefc9b02a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d51180cd-461f-58ad-8f03-20d63965abfb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a7fce165-b445-5aa6-9ec9-6ec8016f4bee","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"a5d17f35-ddfe-5931-bfe4-b7dc039baea0","slug":"definition","fullItemName":"Definition"},{"id":"90888c1e-cd37-5fdf-9d0d-b71e51bf56c3","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"76d2cc5e-4a3e-5032-8eed-d4010ace1ae7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"507a6931-af71-54ae-a8e7-2b4393c2a41b","slug":"complications","fullItemName":"Complications"},{"id":"091f4740-5801-5ac0-83bd-a7ebbc2a2848","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"fc3a9cf3-3dd4-5456-94e1-90c38c83a0b1","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"513fb45b-36c0-59b5-8f88-13b10509caee","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e2100cac-0eb7-55e6-b138-9cbc110f1b71","slug":"investigations","fullItemName":"Investigations"},{"id":"2da7bf77-7798-5632-97d4-64d5463f8cde","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1a1cabda-9d82-5131-8852-db2d844e0b46","slug":"management","fullItemName":"Management","subChapters":[{"id":"f797a7bd-9ca9-523b-8f1e-e2afc927c4ab","slug":"managing-urticaria","fullItemName":"Scenario: Managing urticaria"}]},{"id":"3c7854e6-2fe5-5632-9b63-69f2773b7dd1","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"71f6ce5f-ac94-5ef4-9a02-0aa362883a44","slug":"non-sedating-antihistamines","fullItemName":"Non-sedating antihistamines"},{"id":"8888f0f6-7dd8-55fb-afc0-9e5df55b825a","slug":"sedating-antihistamines","fullItemName":"Sedating antihistamines"},{"id":"b8336773-e3de-5ec0-a85b-93fd72ff7869","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"c88fe5a9-a559-5661-9a1f-e0ee93078a4d","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"e9950b4f-8af1-5d4b-b531-431ac4a731bb","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"729aa2a2-070b-51ed-9ecf-c29549914b66","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a30a2a17-7629-5022-a313-848d8264fb35","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f6d1c75a-6a3d-5326-97ca-baff36370740","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"dd5a897e-e7d5-5c98-88b6-35014f9a5dde","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6d27a969-ded2-5d9d-9321-f65e47426edf","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0d45859d-1b50-538f-84fa-568f43b5c283","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"bfdbbcbf-5a56-51b8-b0aa-78a059b4cfec"}},"staticQueryHashes":["3666801979"]}